These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 12080056
1. Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. Turner RB, Liu L, Sazonova IY, Reed GL. J Biol Chem; 2002 Sep 06; 277(36):33068-74. PubMed ID: 12080056 [Abstract] [Full Text] [Related]
2. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions. Gladysheva IP, Sazonova IY, Chowdhry SA, Liu L, Turner RB, Reed GL. J Biol Chem; 2002 Jul 26; 277(30):26846-51. PubMed ID: 12016220 [Abstract] [Full Text] [Related]
3. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. Collen D, Van Hoef B, Schlott B, Hartmann M, Gührs KH, Lijnen HR. Eur J Biochem; 1993 Aug 15; 216(1):307-14. PubMed ID: 7689966 [Abstract] [Full Text] [Related]
4. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Silence K, Collen D, Lijnen HR. Blood; 1993 Aug 15; 82(4):1175-83. PubMed ID: 7688990 [Abstract] [Full Text] [Related]
5. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin. Sakharov DV, Lijnen HR, Rijken DC. J Biol Chem; 1996 Nov 01; 271(44):27912-8. PubMed ID: 8910391 [Abstract] [Full Text] [Related]
13. A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator. Reed GL, Houng AK, Liu L, Parhami-Seren B, Matsueda LH, Wang S, Hedstrom L. Proc Natl Acad Sci U S A; 1999 Aug 03; 96(16):8879-83. PubMed ID: 10430864 [Abstract] [Full Text] [Related]
14. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. Schneider M, Nesheim M. J Biol Chem; 2004 Apr 02; 279(14):13333-9. PubMed ID: 14715655 [Abstract] [Full Text] [Related]
15. The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Parry MA, Fernandez-Catalan C, Bergner A, Huber R, Hopfner KP, Schlott B, Gührs KH, Bode W. Nat Struct Biol; 1998 Oct 02; 5(10):917-23. PubMed ID: 9783753 [Abstract] [Full Text] [Related]
16. [Plasmin formation in a fibrin network]. Kotschy M, Knapik M. Folia Haematol Int Mag Klin Morphol Blutforsch; 1971 Oct 02; 95(2):167-73. PubMed ID: 4106005 [No Abstract] [Full Text] [Related]
17. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor. Sakai M, Watanuki M, Matsuo O. Biochem Biophys Res Commun; 1989 Jul 31; 162(2):830-7. PubMed ID: 2527034 [Abstract] [Full Text] [Related]
18. Characterization of the murine plasma fibrinolytic system. Lijnen HR, van Hoef B, Beelen V, Collen D. Eur J Biochem; 1994 Sep 15; 224(3):863-71. PubMed ID: 7523120 [Abstract] [Full Text] [Related]
19. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults. Ries M, Klinge J, Rauch R, Keuper H, Harms D. Biol Neonate; 1996 Sep 15; 69(5):298-306. PubMed ID: 8790908 [Abstract] [Full Text] [Related]
20. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin. Leebeek FW, Kluft C, Knot EA, Los P, Cohen AF, Six AJ. J Am Coll Cardiol; 1990 May 15; 15(6):1212-20. PubMed ID: 1691750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]